| 1
Central Venous Catheter (CVC) Product
Product Description
e Arrow® CVC is a central venous catheter manufactured with
medical grade, exible polyurethane. e Arrow®CVC may vary
from two to four noncommunicating lumens. e catheter has a soft
Blue FlexTip® that is more pliable than the catheter body. Lumens
are connected to separate color-coded extension lines which have
hubs on the end that are standard Luer-Lock. Centimeter markings
referenced from the tip are placed along length of indwelling catheter
body to facilitate proper positioning. e kit components assist the
clinician in maintaining maximal sterile barrier precautions (where
provided).
Indications:
e Arrow® CVC is indicated to provide short-term (< 30 days)
central venous access for treatment of diseases or conditions requiring
central venous access including, but not limited to:
•multiple infusions of uids, medications, or chemotherapy
•infusion of uids that are hypertonic, hyperosmolar, or have
divergent pH values
•frequent blood sampling or blood/blood component infusions
•infusion of incompatible medications
•central venous pressure monitoring
•lack of usable peripheral IV sites
•replacement of multiple peripheral sites for IV access
Contraindications:
None known. See additional labeling for product specic
contraindications.
Central Venous Catheter
Warnings and Precautions:
Do not place the catheter into or allow it to remain in the right
atrium or right ventricle (refer to Figure 1).
Figure 1
General Warnings and Precautions
Warnings:
1. Sterile, Single use: Do not reuse, reprocess or resterilize.
Reuse of device creates a potential risk of serious injury
and/or infection which may lead to death.
2. Read all package insert warnings, precautions, and
instructions prior to use. Failure to do so may result in
severe patient injury or death.
3. Practitioners must be aware of complications associated
with central vein catheters including but not limited to:
cardiac tamponade secondary to vessel wall, atrial or
ventricular perforation, pleural (i.e., pneumothorax)
and mediastinal injuries, air embolism, catheter
embolism, catheter occlusion, thoracic duct laceration,
bacteremia, septicemia, thrombosis, inadvertent arterial
puncture, nerve damage, hematoma, hemorrhage, and
dysrhythmias.
4. Do not place Central Venous Catheter (CVC) or
Peripherally Inserted Central Catheter (PICC) into or allow
them to remain in the right atrium or right ventricle.
X-ray exam or other method in compliance with hospital/
institutional protocol must show catheter tip located in
right side of mediastinum in the Superior Vena Cava (SVC)
above its junction with right atrium and parallel to vessel
wall and its distal tip positioned at a level above either
azygos vein or carina of the trachea, whichever is better
visualized. Although cardiac tamponade secondary
to pericardial eusion is uncommon, there is a high
mortality rate associated with it. Improper advancement
of guidewire into the heart has also been implicated in
causing cardiac perforation and tamponade. For femoral
vein approach, catheter should be advanced into vessel
so catheter tip lies parallel to vessel wall and does not
enter right atrium.
5. Ensure catheter tip has not entered the heart or no longer
lies parallel to vessel wall by performing an x-ray exam or
other method in compliance with hospital/institutional
protocol. If catheter position has changed, immediately
re-evaluate.
6. Practitioners must be aware of the potential for
entrapment of guidewire by any implanted device in
circulatory system (i.e., vena cava lters, stents). Review
patient’s history before catheterization procedure to
assess for possible implants. Care should be taken
regarding length of guidewire inserted. It is recommended
that if patient has a circulatory system implant, catheter
procedure be done under direct visualization to minimize
the risk of guidewire entrapment.
